General form of registration statement for all companies including face-amount certificate companies

Subsequent Events (Detail Textuals)

v3.8.0.1
Subsequent Events (Detail Textuals) - USD ($)
 1 Months Ended 2 Months Ended 12 Months Ended
Feb. 16, 2018
Jan. 19, 2018
Jan. 18, 2018
Feb. 28, 2018
Dec. 31, 2016
Dec. 31, 2017
Nov. 30, 2017
Mar. 31, 2017
Jan. 31, 2017
Oct. 31, 2016
Aug. 20, 2015
Subsequent Event [Line Items]                      
Common stock, par value (in dollars per share)         $ 0.001 $ 0.001   $ 0.001      
Common stock gross proceeds         $ 407,669            
Series B Preferred Stock                      
Subsequent Event [Line Items]                      
Shares issued, price per share (in dollars per share)         $ 0.25           $ 0.80
Preferred stock shares convertible into common stock         16,124,000 28,335,500          
Warrant exercise price (in dollars per share)             $ 0.15   $ 0.25    
Series C Preferred Stock                      
Subsequent Event [Line Items]                      
Warrant exercise price (in dollars per share)                   $ 0.40  
Subsequent Event | Securities purchase agreement | Emerald Health Sciences Inc                      
Subsequent Event [Line Items]                      
Shares issued, price per share (in shares)   15,000,000                  
Shares issued, price per share (in dollars per share)   $ 0.10                  
Funds received under the Secured Promissory Note   $ 400,000                  
Common stock issued 15,000,000                    
Common stock, par value (in dollars per share) $ 0.001                    
Number of common stock called by warrant 20,400,000 20,400,000                  
Warrant exercise price (in dollars per share) $ 0.10                    
Term of warrants 5 years                    
Common stock gross proceeds   $ 1,500,000                  
Subsequent Event | Securities purchase agreement | Emerald Health Sciences Inc | Bridge Loan                      
Subsequent Event [Line Items]                      
Aggregate gross proceeds   $ 900,000                  
Conversion price, per share (in dollars per share)   $ 0.10                  
Shares converted into common stock   9,000,000                  
Subsequent Event | Securities purchase agreement | Emerald Health Sciences Inc | Accredited investor                      
Subsequent Event [Line Items]                      
Common stock issued 2,500,000                    
Number of common stock called by warrant 3,400,000                    
Warrant exercise price (in dollars per share) $ 0.10                    
Term of warrants 5 years                    
Common stock gross proceeds $ 1,750,000                    
Subsequent Event | Restricted Stock Agreements                      
Subsequent Event [Line Items]                      
Restricted stock vesting percentage     50.00%                
Subsequent Event | Restricted Stock Agreements | Common Stock | Immediate vesting                      
Subsequent Event [Line Items]                      
Number of restricted common stock vested       900,000              
Subsequent Event | Restricted Stock Agreements | Common Stock | October 20, 2015                      
Subsequent Event [Line Items]                      
Number of restricted common stock vested       325,000              
Subsequent Event | Restricted Stock Agreements | Common Stock | November 21, 2014                      
Subsequent Event [Line Items]                      
Number of restricted common stock vested       125,000              
Subsequent Event | Restricted Stock Agreements | Dr. Brian S. Murphy                      
Subsequent Event [Line Items]                      
Shares of restricted common stock     900,000                
Subsequent Event | Restricted Stock Agreements | Elizabeth Berecz, CFO                      
Subsequent Event [Line Items]                      
Shares of restricted common stock     700,000                
Subsequent Event | Restricted Stock Agreements | Cosmas N. Lykos                      
Subsequent Event [Line Items]                      
Shares of restricted common stock     900,000                
Subsequent Event | Separation and release agreement | K2C, Inc.                      
Subsequent Event [Line Items]                      
Common stock gross proceeds       $ 180,000              
Subsequent Event | Common stock purchase warrant agreement | Common Stock                      
Subsequent Event [Line Items]                      
Number of restricted common stock vested       1,110,000